Cytokinetics, Inc. (CYTK)

[Solantey]

Substantial improvement:

SOUTH SAN FRANCISCO, CA, May 6, 2014 - Cytokinetics, Incorporated (CYTK) reported total revenues of $8.0 million for the first quarter of 2014, compared to $0.8 million during the same period in 2013. Net loss for the first quarter of 2014 was $8.7 million or $0.27 per basic share and diluted share. This is compared to a net loss for the same period in 2013, of $12.6 million, or $0.53 per basic and diluted share. As of March 31, 2014, [color=red]cash, cash equivalents and investments totaled $101.9 million.[/color]